Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$2.04M Sell
85,554
-2,077
-2% -$51.3K 0.12% 154
2025
Q2
$2.12M Sell
87,631
-3,855
-4% -$89.9K 0.13% 144
2025
Q1
$2.31M Sell
91,486
-5,675
-6% -$148K 0.16% 128
2024
Q4
$2.57M Sell
97,161
-8,478
-8% -$230K 0.17% 129
2024
Q3
$3.07M Sell
105,639
-1,779
-2% -$51.9K 0.21% 117
2024
Q2
$2.99M Sell
107,418
-30,519
-22% -$840K 0.21% 113
2024
Q1
$3.83M Sell
137,937
-4,330
-3% -$120K 0.27% 96
2023
Q4
$4.1M Sell
142,267
-92,643
-39% -$2.8M 0.31% 91
2023
Q3
$7.54M Sell
234,910
-65,790
-22% -$2.33M 0.61% 46
2023
Q2
$10.9M Sell
300,700
-14,028
-4% -$546K 0.86% 36
2023
Q1
$12.7M Buy
314,728
+35,368
+13% +$1.53M 1.05% 24
2022
Q4
$14.3M Sell
279,360
-7,973
-3% -$382K 1.25% 16
2022
Q3
$12.7M Buy
287,333
+13,298
+5% +$646K 1.21% 17
2022
Q2
$14M Sell
274,035
-24,755
-8% -$1.26M 1.29% 15
2022
Q1
$15.7M Buy
+298,790
New +$15.5M 1.36% 15

Other funds holding PFE

Country Club Bank's PFE Position: Q3 2025 in Review

Country Club Bank reduced its Pfizer (PFE) stake by 2.4% in Q3 2025, selling an estimated $51.3K and leaving 85,554 shares worth $2.04M. The position accounts for 0.12% of the portfolio, ranked #154.

Country Club Bank first reported a position in PFE in Q1 2022 and has held it in 15 quarters since. The position peaked at $15.7M in Q1 2022. 2,812 funds tracked by Wall St. Rank hold PFE as of Q3 2025.

  • Country Club Bank held 85,554 shares of Pfizer worth $2.04M as of Q3 2025.
  • Country Club Bank sold 2,077 Pfizer shares in Q3 2025, an estimated $51.3K.
  • Pfizer made up 0.12% of Country Club Bank's portfolio in Q3 2025, its #154 holding.
  • Country Club Bank first reported a position in Pfizer in Q1 2022 and has held it in 15 quarters since.
  • Country Club Bank's Pfizer position peaked at $15.7M in Q1 2022.
  • 2,812 funds tracked by Wall St. Rank held Pfizer as of Q3 2025.

Based on Country Club Bank's 13F filing for Q3 2025, filed 8 Oct 2025.